Anzeige
Meldung des Tages: 221 % Kursgewinn – und jetzt kommt der größte Trigger: FDA-Entscheidung steht bevor

QuidelOrtho News

Aktie
WKN:  A3DNGX ISIN:  US2197981051 US-Symbol:  QDEL Branche:  Gesundheitswesen: Ausstattung u. Produkte Land:  USA
16,602 €
-0,014 €
-0,08%
07:30:36 Uhr
Depot/Watchlist
Marktkapitalisierung *
1,68 Mrd. €
Streubesitz
-10,98%
KGV
-
Index-Zuordnung
-

QuidelOrtho News

19.02.26 - PR Newswire
Faster Cardiac Answers with High‑Sensitivity Troponin
Faster Cardiac Answers with High‑Sensitivity Troponin PR Newswire
18.02.26 - PR Newswire
QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference
QuidelOrtho to Present at the 47th Annual Raymond James Institutional Investor Conference PR Newswire
16.02.26 - PR Newswire
QuidelOrtho geht strategische Liefervereinbarung zur Erweiterung des globalen Immunoassay-Portfolios ein
QuidelOrtho geht strategische Liefervereinbarung zur Erweiterung des globalen Immunoassay-​Portfolios ein PR Newswire
16.02.26 - PR Newswire
QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio
QuidelOrtho Enters Strategic Supply Agreement to Expand Global Immunoassay Portfolio PR Newswire
11.02.26 - PR Newswire
QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results
QuidelOrtho Reports Fourth Quarter and Full-Year 2025 Financial Results PR Newswire
03.02.26 - PR Newswire
QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie® Awards
QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie® Awards PR Newswire
22.01.26 - PR Newswire
Strengthening the blood supply: Awareness, challenges and donor impact
Strengthening the blood supply: Awareness, challenges and donor impact PR Newswire
21.01.26 - PR Newswire
QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results PR Newswire
18.12.25 - PR Newswire
Innovating Diagnostics and What's Next
Innovating Diagnostics and What's Next PR Newswire
24.11.25 - PR Newswire
QuidelOrtho To Participate In Upcoming Investor Conferences
QuidelOrtho To Participate In Upcoming Investor Conferences PR Newswire
20.11.25 - PR Newswire
The Power of Prevention: Detecting Diabetes Before It Strikes
The Power of Prevention: Detecting Diabetes Before It Strikes PR Newswire
05.11.25 - PR Newswire
QuidelOrtho Reports Third Quarter 2025 Financial Results
QuidelOrtho Reports Third Quarter 2025 Financial Results PR Newswire
03.11.25 - PR Newswire
QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay
QuidelOrtho Receives FDA 510(k) Clearance for VITROS™ Immunodiagnostic Products hs Troponin I Assay PR Newswire
23.10.25 - PR Newswire
Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics
Informatics Illuminated: Science Bytes Podcast Explores the Power Behind Smarter Diagnostics PR Newswire
22.10.25 - PR Newswire
QuidelOrtho to Report Third Quarter 2025 Financial Results
QuidelOrtho to Report Third Quarter 2025 Financial Results PR Newswire
16.10.25 - PR Newswire
QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025
QuidelOrtho Showcases Leadership in Transfusion Medicine at AABB 2025 PR Newswire
25.09.25 - PR Newswire
Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters
Through Shades of Illness: Science Bytes Podcast Discusses Why Testing Matters PR Newswire
22.09.25 - PR Newswire
QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use
QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use PR Newswire
28.08.25 - PR Newswire
QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference
QuidelOrtho to Participate in the Baird 2025 Global Healthcare Conference PR Newswire
21.08.25 - PR Newswire
QuidelOrtho Completes Debt Refinancing
QuidelOrtho Completes Debt Refinancing PR Newswire

Newssuche

Videos

newspaper
10.03.26 +38,58%
Technical Trading: DAX Long Chance
DAX Long Typ: Turbo Open End WKN: VK2CGA Hebel:11,30 Laufzeit: OpenEnd Einstieg: Market ... Mehr »